Hemostasis Diagnostics Market by End-user and Geography - Forecast and Analysis 2022-2026
| Published: Feb 2022 | Pages: 120 | SKU: IRTNTR72488 |
The hemostasis diagnostics market share is expected to increase by USD 1.12 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.95%.
This hemostasis diagnostics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers hemostasis diagnostics market segmentation by end-user (hospitals and clinics, independent diagnostic centers, and research and academic institutions) and geography (North America, Europe, Asia, and the Rest of World (ROW)). The hemostasis diagnostics market report also offers information on several market vendors, including Abbott Laboratories, Beckman Coulter Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Helena Laboratories Corp., Hitachi Ltd., HORIBA Ltd., Medtronic Plc, Nihon Kohden Corp., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc. among others.
What will the Hemostasis Diagnostics Market Size be During the Forecast Period?
Download the Free Report Sample to Unlock the Hemostasis Diagnostics Market Size for the Forecast Period and Other Important Statistics
Hemostasis Diagnostics Market: Key Drivers, Trends, and Challenges
The increasing prevalence of coagulation disorders driving the demand for hemostasis diagnostics is notably driving the hemostasis diagnostics market growth, although factors such as high cost of fully-automated hemostasis equipment may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the hemostasis diagnostics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Hemostasis Diagnostics Market Driver
One of the key factors driving the global hemostasis diagnostics market growth is the increasing prevalence of coagulation disorders, such as Von Willebrand disease, deep venous thrombosis, hypercoagulable states, and clotting factor deficiencies. For instance, according to the data published by the CDC in July 2020, nearly 400 babies are born with hemophilia A, every year in the US. In addition, according to the data stated by the CDC in February 2020, nearly 900,000 people in the US are affected by venous thromboembolism, which is also known as deep vein thrombosis/pulmonary embolism (DVT/PE), every year. Furthermore, coagulation tests are recommended by physicians during major surgeries. This will increase the demand for hemostasis diagnostics, which will drive the growth of the global hemostasis diagnostics market in the forecast period.
Key Hemostasis Diagnostics Market Trend
Another key factor driving the global hemostasis diagnostics market growth is the increase in the demand for POCT hemostasis diagnostics in countries such as Spain and UK. Spain is ranked seventh in the world by the World Health Organization (WHO) for its universal public healthcare system. Its public healthcare is free and covers all citizens for services, including diagnostic and therapeutic techniques and preventive care. Similarly, in the UK, the NHS follows the universal concept of coverage. Citizens of the UK are entitled to use free healthcare services at point-of-care. Thus, manufacturers are focusing on cost-effectiveness as a critical factor for developing devices with effective design. In addition, tests performed with POC testing devices reduce the chances of cross-contamination of samples collected, which is influencing hospitals and clinics to shift toward hemostasis diagnostics. Such factors are expected to further support the growth of the market in focus in the forecast period.
Key Hemostasis Diagnostics Market Challenge
One of the key challenges to the global hemostasis diagnostics market growth is the high cost of fully-automated hemostasis equipment. The launch of a new product from the R&D stage to commercialization is a very expensive process. Furthermore, many big companies are facing the problem of frequent elimination of hemostasis diagnostics products due to technological obsolescence with the entry of new technologies in the market. The total cost of POCT involves devices, reagents, test tubes, control solutions, and maintenance costs, which generally exceed traditional lab testing costs. For instance, combined viscoelastic and aggregometry coagulation testing costs USD 52 to USD 60, while a conventional test battery costs less than USD 18. In addition, there are reimbursement restrictions on a few POC tests. Such factors are expected to negatively impact the market during the forecast period.
This hemostasis diagnostics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Parent Market Analysis
Technavio categorizes the global hemostasis diagnostics market as a part of the pharmaceutical market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the hemostasis diagnostics market during the forecast period.
Who are the Major Hemostasis Diagnostics Market Vendors?
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
- Abbott Laboratories
- Beckman Coulter Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Grifols SA
- Helena Laboratories Corp.
- Hitachi Ltd.
- HORIBA Ltd.
- Medtronic Plc
- Nihon Kohden Corp.
- Siemens AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
This statistical study of the hemostasis diagnostics market encompasses successful business strategies deployed by the key vendors. The hemostasis diagnostics market is concentrated and the vendors are deploying growth strategies such as focussing on R&D activities for developing advanced, high-quality products and strengthening their product offerings to compete in the market.
Product Insights and News
- abbott.com - The company offers hemostasis diagnostics machines under the brand name Alinity.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The hemostasis diagnostics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Hemostasis Diagnostics Market Value Chain Analysis
Our report provides extensive information on the value chain analysis for the hemostasis diagnostics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
Which are the Key Regions for Hemostasis Diagnostics Market?
For more insights on the market share of various regions Request for a FREE sample now!
50% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for hemostasis diagnostics in North America. Market growth in this region will be faster than the growth of the market in other regions.
The increasing prevalence of chronic diseases and the growing geriatric population will facilitate the hemostasis diagnostics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The cases of COVID-19 increased significantly across North America in 2020. For instance, according to the Centers for Medicare and Medicaid Services (CMS), healthcare expenditure in the US was around USD 11,582 per person in 2019, an increase of 4.6% from the previous year. Such factors are increasing the demand for various advanced products required for coagulation tests, which thereby propels the growth of the hemostasis diagnostics market in North America.
What are the Revenue-generating End-user Segments in the Hemostasis Diagnostics Market?
To gain further insights on the market contribution of various segments Request for a FREE sample
The hemostasis diagnostics market share growth by the hospitals and clinics segment will be significant during the forecast period. The growth is attributed to the rise in the number of hospitalization of people with serious cases for basic monitoring during surgeries, which results in hospitals increasing their investments in hemostasis diagnostics.
This report provides an accurate prediction of the contribution of all the segments to the growth of the hemostasis diagnostics market size and actionable market insights on post COVID-19 impact on each segment.
You may be interested in:
Hemostasis Valve market - The market share is expected to increase by USD 73.7 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.98%.
Influenza Diagnostics market - The market has the potential to grow by USD 401.89 million during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 7.09%.
Tissue Diagnostics market - The market size is expected to grow by $ 2.56 bn and record a CAGR of 9% during 2020-2024.
|
Hemostasis Diagnostics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.95% |
|
Market growth 2022-2026 |
$ 1.12 billion |
|
Market structure |
Concentrated |
|
YoY growth (%) |
7.38 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 50% |
|
Key consumer countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
Abbott Laboratories, Beckman Coulter Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Helena Laboratories Corp., Hitachi Ltd., HORIBA Ltd., Medtronic Plc, Nihon Kohden Corp., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Hemostasis Diagnostics Market Report?
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will drive hemostasis diagnostics market growth during the next five years
- Precise estimation of the hemostasis diagnostics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the hemostasis diagnostics industry across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of hemostasis diagnostics market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by End-user
- 5.1 Market segments
- Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
- Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
- 5.2 Comparison by End-user
- Exhibit 26: Chart on Comparison by End-user
- Exhibit 27: Data Table on Comparison by End-user
- 5.3 Hospitals and clinics - Market size and forecast 2021-2026
- Exhibit 28: Chart on Hospitals and clinics - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Hospitals and clinics - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Hospitals and clinics - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Hospitals and clinics - Year-over-year growth 2021-2026 (%)
- 5.4 Independent diagnostic centers - Market size and forecast 2021-2026
- Exhibit 32: Chart on Independent diagnostic centers - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Independent diagnostic centers - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Independent diagnostic centers - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Independent diagnostic centers - Year-over-year growth 2021-2026 (%)
- 5.5 Research and academic institutions - Market size and forecast 2021-2026
- Exhibit 36: Chart on Research and academic institutions - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Research and academic institutions - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Research and academic institutions - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Research and academic institutions - Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by End-user
- Exhibit 40: Market opportunity by End-user ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 UK - Market size and forecast 2021-2026
- Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10 China - Market size and forecast 2021-2026
- Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.11 Canada - Market size and forecast 2021-2026
- Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 Abbott Laboratories
- Exhibit 89: Abbott Laboratories - Overview
- Exhibit 90: Abbott Laboratories - Business segments
- Exhibit 91: Abbott Laboratories - Key news
- Exhibit 92: Abbott Laboratories - Key offerings
- Exhibit 93: Abbott Laboratories - Segment focus
- 10.4 Beckman Coulter Inc.
- Exhibit 94: Beckman Coulter Inc. - Overview
- Exhibit 95: Beckman Coulter Inc. - Product / Service
- Exhibit 96: Beckman Coulter Inc. - Key offerings
- 10.5 F. Hoffmann La Roche Ltd.
- Exhibit 97: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 98: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 99: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 100: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 101: F. Hoffmann La Roche Ltd. - Segment focus
- 10.6 Grifols SA
- Exhibit 102: Grifols SA - Overview
- Exhibit 103: Grifols SA - Business segments
- Exhibit 104: Grifols SA - Key offerings
- Exhibit 105: Grifols SA - Segment focus
- 10.7 Helena Laboratories Corp.
- Exhibit 106: Helena Laboratories Corp. - Overview
- Exhibit 107: Helena Laboratories Corp. - Product / Service
- Exhibit 108: Helena Laboratories Corp. - Key offerings
- 10.8 HORIBA Ltd.
- Exhibit 109: HORIBA Ltd. - Overview
- Exhibit 110: HORIBA Ltd. - Business segments
- Exhibit 111: HORIBA Ltd. - Key news
- Exhibit 112: HORIBA Ltd. - Key offerings
- Exhibit 113: HORIBA Ltd. - Segment focus
- 10.9 Medtronic Plc
- Exhibit 114: Medtronic Plc - Overview
- Exhibit 115: Medtronic Plc - Business segments
- Exhibit 116: Medtronic Plc - Key news
- Exhibit 117: Medtronic Plc - Key offerings
- Exhibit 118: Medtronic Plc - Segment focus
- 10.10 Siemens AG
- Exhibit 119: Siemens AG - Overview
- Exhibit 120: Siemens AG - Business segments
- Exhibit 121: Siemens AG - Key news
- Exhibit 122: Siemens AG - Key offerings
- Exhibit 123: Siemens AG - Segment focus
- 10.11 Sysmex Corp.
- Exhibit 124: Sysmex Corp. - Overview
- Exhibit 125: Sysmex Corp. - Business segments
- Exhibit 126: Sysmex Corp. - Key offerings
- Exhibit 127: Sysmex Corp. - Segment focus
- 10.12 Thermo Fisher Scientific Inc.
- Exhibit 128: Thermo Fisher Scientific Inc. - Overview
- Exhibit 129: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 130: Thermo Fisher Scientific Inc. - Key news
- Exhibit 131: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 132: Thermo Fisher Scientific Inc. - Segment focus
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 133: Inclusions checklist
- Exhibit 134: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 135: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 136: Research methodology
- Exhibit 137: Validation techniques employed for market sizing
- Exhibit 138: Information sources
- 11.5 List of abbreviations
- Exhibit 139: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
hemostasis diagnostics market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis